Lisa Dumkow

How up to date is your HIV knowledge? Ready to elevate your HIV practice with the latest evidence? Register now for the interactive and application-based HIV workshop on 5/14/26 at the @MAD_ID_ASP and @SIDPharm Annual meeting! Register here: buff.ly/IgFHkJV

Struggling to optimize Outpatient Parenteral Antimicrobial Therapy (OPAT)? Learn from the best! Register now for the interactive and application-based OPAT workshop on 5/14/26 at the @MAD_ID_ASP and @SIDPharm Annual meeting. Register here: buff.ly/IgFHkJV

It’s here! Registration is open for the 2026 MAD-ID/SIDP Annual meeting! Members can take advantage of a reduced price for this week only during lightning registration! Hope to see you in Orlando! Register here: buff.ly/B99rlmo

Lightning registration for the 2026 MAD-ID - SIDP Annual Meeting opens on Tuesday for one week only 1/20-1/27. Don’t miss out on the $499 member price! *Additional $10 per BCIDP credit claimed. Hope to see you there! @SIDPharm

GN-BSI Stewardship 🆕💫🦠 ICHE 2025: In a 22-hospital system (3,231 patients), GN-BSI care became shorter, safer, and more oral. 🚀 What changed 1️⃣ OPAT review for all planned IV discharges 2️⃣ GN-BSI guideline → oral step-down + 7-day therapy criteria 🔥 Key wins 💉 IV at discharge: 22.7% → 9.2% ⏳ Duration: 13.5 → 10.7 days* ✂️ <10 days: 19% → 45% 💊 More TMP-SMX & cephalexin; fewer FQs 📈 Correct oral β-lactam dosing: 2.8% → 33.5% 🛡️ Safety unchanged (recurrence, mortality, C. diff) 💡 Takeaway Shorter wins. Oral works. Safety holds. *7 days based on BALANCE is the optimal duration #IDXposts cambridge.org/core/journals/…

🤩 Honored to speak at the IDWeek 2025, in Atlanta, Georgia 🇺🇸 In case you missed the session on Expanding Global Stewardship Through Cultural Humility and Community Engagement, access IDWeek on demand for registered delegates at cdmcd.co/3RprjX

🔔 Register & catch the first webinar tomorrow, co-moderated by @SIDPharm member and InterOrg Vice Chair @kristadgens! #IDSky #AMR

🆕💫 Retrospective, multicenter cohort study(N: 367) Cefdinir was independently associated with treatment failure with nearly twice as high of failure rate compared with cephalexin for the treatment of outpatient uncomplicated UTI #IDXposts #UTIWiki academic.oup.com/ofid/article/1…

@AtheerAldairem @ABsteward

‼️Just shared at #IDWeek2025, our findings are now published in @OFIDJournal comparing cephalexin to cefdinir for uUTI in females. Spoiler: cefdinir was the only independent risk factor associated with/failure. Poor urinary PK = ⬆️failure. Let’s stop Rx’ing cefdinir for UTI! 🛑💊

👋 I have a few copies of the drug name emoji game deck of cards for only $20. Find me at #IDweek2025

Today is the day! Join us for the @SIDPharm Poster Walk, led by SIDP Paper of the Year award winners, Ryan Shields & Jason Pogue! Meet us at the SIDP booth at 12:30 to join the fun & learn from our experts! #IDWeek2025 #SIDP2025

At #IDWeek2025? Be sure to stop by the @SIDPharm Booth for more amazing swag, photo ops, & our poster walk today! #SIDP2025

Step into the shoes of the stewardship team for “A Day with the Antimicrobial Stewardship Pager,” presented by @LisaIDpharmD, @RebeccaSame, Christine Lockowitz, PharmD, BCIDP, @DrKevinSchwartz, @EStohs, and @NPT_PharmD.

New episode alert! ‼️ Breakpoints first multi-language episode! Check out episode #122, focused on antimicrobial stewardship in Latin America. So grateful for all team members who worked diligently to bring this project to life! #NewEpisode #Breakpoints

‼️Excited to share our work (just in time for URI season!) implementing order sentences for URI supportive care as an effective way to reduce outpatient abx prescribing. Shout out to our incredible AmbCare team partnering to implement this intervention! doi.org/10.1017/ash.20…

Not posting much on here these days, but had to give a shout out to former student & current HFH PGY2 ID resident @Cole_Orlikowski on his 1st publication! Check out our thoughts on risk factors to consider when implementing lipoglycopeptides in the ED! journals.sagepub.com/doi/10.1177/10…

Excited to share this work published in @ASHE_Journal completed by our recent pharmacy resident graduates, Mackenzie Miller & @NoahBID! We have a lot of work to do in the outpatient setting to improve prescribing for SSTIs 💊 #outpatientstewie

🚨 New @SIDPharm #Breakpoints Episode! 🎙️ Join Drs. @Cortes_Penfield, @JessieLSeidel, @Kerry_LaPlante, & me to discuss biofilms in PJIs. 🧫, what the lab tells us about the best drugs 💊, & the innovative non-pharmacological strategies (more than just 🦴 cement!). #IDTwitter

📢 ‼️ Have you ever wanted to host Breakpoints? Now is your chance! Looking for engaging @SIDPharm members to audition to host everyone’s favorite podcast. Details can be found at: buff.ly/4hcICmI